To Evaluate Perfusion Changes to the Liver Following Pr-operative Portal Vein Embolization for Patients with Liver Cancer
MD Anderson Study Status
This trial studies the use of computed tomography (CT) perfusion scans in detecting changes in blood flow to the liver after portal vein embolization in patients with liver cancer. CT perfusion scans use a standard contrast drug given by vein to measure blood flow to the liver. CT perfusion scans may predict the rate and amount of growth of new, healthy tissue on one side of the liver after a portal vein embolization and detect change to the size of the liver tumor as result of the procedure.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Liver and Intrahepatic Bile Duct Carcinoma
For general questions about clinical trials: